Catherine A Hammett-Stabler

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint HbA1c as a postmortem tool to identify glycemic control
    Ruth E Winecker
    North Carolina Office of the Chief Medical Examiner, University of North Caolina, Chapel Hill 27599 7580, USA
    J Forensic Sci 47:1373-9. 2002
  2. doi request reprint An introduction to drug testing: the expanding role of mass spectrometry
    Catherine Hammett-Stabler
    Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Methods Mol Biol 902:1-13. 2012
  3. ncbi request reprint Urine drug screening in the medical setting
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA
    Clin Chim Acta 315:125-35. 2002
  4. ncbi request reprint The use of biochemical markers in osteoporosis
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, Campus Box 7525, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Lab Med 24:175-97. 2004
  5. doi request reprint A case of hook effect in the serum free light chain assay using the Olympus AU400e
    Christopher R McCudden
    University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, CB 7525 Chapel Hill, NC 27599 7525, USA
    Clin Biochem 42:121-4. 2009
  6. doi request reprint Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay
    Steven W Cotten
    Department of Pathology and Laboratory Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Biochem 45:605-9. 2012
  7. pmc Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
    Timothy J Ives
    Division of General Internal Medicine and Clinical Epidemiology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    BMC Health Serv Res 6:46. 2006
  8. doi request reprint The evolution of mass spectrometry in the clinical laboratory
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599 7525, USA
    Methods Mol Biol 603:1-7. 2010
  9. doi request reprint Monitoring of mycophenolate acid in serum or plasma using LC tandem mass spectrometry
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Methods Mol Biol 603:379-87. 2010
  10. doi request reprint Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins
    Christopher R McCudden
    Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Am J Clin Pathol 129:451-8. 2008

Detail Information

Publications10

  1. ncbi request reprint HbA1c as a postmortem tool to identify glycemic control
    Ruth E Winecker
    North Carolina Office of the Chief Medical Examiner, University of North Caolina, Chapel Hill 27599 7580, USA
    J Forensic Sci 47:1373-9. 2002
    ..8. For six unknowns whose values exceeded 7.0%. the mean was 11.7%, which did not differ statistically from the diabetic mean (p = 0.6615). These studies suggest that postmortem blood samples can be used to characterize HbA1c values...
  2. doi request reprint An introduction to drug testing: the expanding role of mass spectrometry
    Catherine Hammett-Stabler
    Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Methods Mol Biol 902:1-13. 2012
    ..This chapter introduces the reader to the application of MS to TDM and toxicology, the steps that should be considered during implementation, and the processes that should be implemented to assure continued quality...
  3. ncbi request reprint Urine drug screening in the medical setting
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA
    Clin Chim Acta 315:125-35. 2002
    ..The reasons for these include the drugs involved, the sample, the methods utilized to perform the tests, and the level of understanding of the physician using the data, all of which are closely related to the other...
  4. ncbi request reprint The use of biochemical markers in osteoporosis
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, Campus Box 7525, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Lab Med 24:175-97. 2004
    ..Regardless of the process, a key pathologic development is the net loss of bone mass. This article reviews the use of biochemical markers in osteoporosis...
  5. doi request reprint A case of hook effect in the serum free light chain assay using the Olympus AU400e
    Christopher R McCudden
    University of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, CB 7525 Chapel Hill, NC 27599 7525, USA
    Clin Biochem 42:121-4. 2009
    ..Serial dilution of the patient's serum specimen revealed that the serum free lambda light chain was actually 3130 mg/L. This case represents an example of antigen excess or 'hook effect' using the serum free light chain assay...
  6. doi request reprint Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay
    Steven W Cotten
    Department of Pathology and Laboratory Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Biochem 45:605-9. 2012
    ....
  7. pmc Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
    Timothy J Ives
    Division of General Internal Medicine and Clinical Epidemiology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    BMC Health Serv Res 6:46. 2006
    ..We conducted a prospective cohort study to determine the one-year incidence and predictors of opioid misuse among patients enrolled in a chronic pain disease management program within an academic internal medicine practice...
  8. doi request reprint The evolution of mass spectrometry in the clinical laboratory
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599 7525, USA
    Methods Mol Biol 603:1-7. 2010
    ..It is not uncommon any more to see mass spectrometry being used in the routine clinical laboratories...
  9. doi request reprint Monitoring of mycophenolate acid in serum or plasma using LC tandem mass spectrometry
    Catherine A Hammett-Stabler
    Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Methods Mol Biol 603:379-87. 2010
    ..We describe an LC-MS-MS that permits the measurement of MPA and 7-O-glucuronide mycophenolic acid (MPAG) in serum or plasma...
  10. doi request reprint Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins
    Christopher R McCudden
    Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    Am J Clin Pathol 129:451-8. 2008
    ..58 to 1.73). CE is an analytically suitable alternative to AGE, but laboratories implementing it will need to continue IFE testing to characterize all M proteins detected by CE...